Kinetic River Awarded 3-Year Grant

Kinetic River has been awarded a three-year grant from the The National Institutes of Health!

This Commercialization Readiness Program grant follows previous SBIR Phase I and Phase II awards, and is provided by the NIH’s National Institute of General Medical Sciences (NIGMS), the organization that has supplied the majority of our research funding to date. This brings our total NIH grants to seven, including two Phase II’s and one CRP, for over $8M in nondilutive funding—for which we are immensely grateful.

It will help continue the development of the Arno Compensation-Free Flow Cytometer and pave the way toward market launch, by reducing instrument cost and expanding the array of monoclonal antibody conjugates validated for use on it.

This grant represents a huge recognition, through peer review, by the NIH—a testament to the promise of our Time-Resolved technology and to the benefits it is intended to bring to the flow cytometry user base.